J&J, Safe, Solid, & Consistent
Read the full article at: http://www.thediv-net.com/2008/10/j-safe-solid-consistent.html
Submitted by Dividend Growth... on Wed, 2008-10-15 15:35.
(via www.thediv-net.com)
Global health care company and perennial dividend grower, Johnson & Johnson (JNJ) announced yesterday that they grew their third quarter earnings by 10.4% over 2007. Sales were up across the board and were largely driven by international efforts. Generic drugs are having a negative impact on J&J's pharmaceutical business. Johnson managed to grow consumer sales by 13% driven primarily be U.S. allergy sales (Zyrtec) and Chinese moisturizer sales (Dabao).
